Skip to main content

Market Overview

20 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Share:

Gainers

Immutep, Inc. (NASDAQ:IMMP) shares increased by 65.45% to $1.82 during Wednesday's pre-market session.

RTI Surgical Hldgs, Inc. (NASDAQ:RTIX) shares increased by 20.35% to $4.08.

Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares moved upwards by 18.57% to $0.83. The most recent rating by H.C. Wainwright, on May 6, is at Neutral, with a price target of $5.

Moderna, Inc. (NASDAQ:MRNA) shares increased by 16.87% to $87.70. The most recent rating by Brookline Capital, on Jul 13, is at Buy, with a price target of $95.

TherapeuticsMD, Inc. (NASDAQ:TXMD) stock moved upwards by 16.10% to $1.73. According to the most recent rating by JP Morgan, on May 19, the current rating is at Neutral.

VBI Vaccines, Inc. (NASDAQ:VBIV) stock moved upwards by 14.85% to $5.18.

Novan, Inc. (NASDAQ:NOVN) shares rose 10.80% to $0.56.

Fluidigm, Inc. (NASDAQ:FLDM) stock increased by 9.42% to $5.92.

Orchard Therapeutics, Inc. (NASDAQ:ORTX) stock moved upwards by 9.37% to $5.60.

ReWalk Robotics, Inc. (NASDAQ:RWLK) shares increased by 8.40% to $1.29.

 

Losers

Zynex, Inc. (NASDAQ:ZYXI) stock decreased by 11.14% to $23.30 during Wednesday's pre-market session. According to the most recent rating by B. Riley FBR, on Jul 13, the current rating is at Neutral.

Endologix, Inc. (NASDAQ:ELGX) stock declined 10.73% to $0.26. According to the most recent rating by BTIG, on May 12, the current rating is at Neutral.

IMV, Inc. (NASDAQ:IMV) stock declined 8.86% to $4.22. The most recent rating by Wells Fargo, on May 18, is at Overweight, with a price target of $8.

Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock fell 8.26% to $3.

Myos Rens Technology, Inc. (NASDAQ:MYOS) stock fell 7.76% to $1.19.

Dynatronics, Inc. (NASDAQ:DYNT) stock declined 6.69% to $0.77. The most recent rating by Aegis Capital, on May 19, is at Buy, with a price target of $1.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock declined 6.67% to $3.85. The most recent rating by JP Morgan, on May 27, is at Overweight, with a price target of $6.

Dare Bioscience, Inc. (NASDAQ:DARE) shares fell 6.58% to $1.42. The most recent rating by Brookline Capital, on Apr 28, is at Buy, with a price target of $8.

Vaxart, Inc. (NASDAQ:VXRT) shares declined 5.13% to $16.10. The most recent rating by B. Riley FBR, on Jul 13, is at Buy, with a price target of $22.

INmune Bio, Inc. (NASDAQ:INMB) shares declined 5.08% to $14.95. The most recent rating by HC Wainwright & Co., on Jul 15, is at Buy, with a price target of $20.

 

Related Articles (RTIX + IMMP)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com